Pilar Portolés

Dr. Pilar Portolés

orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1988 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
CJCharles A. Janeway Jr.
Charles A. Janeway Jr.
SCSimon Carding
Simon Carding
BJBarry Jones
Barry Jones
JMJoseph Murray
Joseph Murray
PPPilar Portolés
Pilar Portolés
KBKim Bottomly
Kim Bottomly

1 March 2010 in Acta Biomaterialia
Verified
Journal Article
Closed access
MAM. Alcaide
M. Alcaide
PPPilar Portolés
Pilar Portolés
ALA. López-Noriega
A. López-Noriega
Daniel ArcosDaniel Arcos
Daniel Arcos
MVM. Vallet-Regí
M. Vallet-Regí
MPMaría Teresa Portolés
María Teresa Portolés

1 January 1989 in Cold Spring Harbor Symposia on Quantitative Biology
Verified
Journal Article
Open access
PDF file
CJC.A. Janeway
C.A. Janeway
UDU. Dianzani
U. Dianzani
PPPilar Portolés
Pilar Portolés
SRS. Rath
S. Rath
ERE.-P. Reich
E.-P. Reich
DMD.B. Murphy
D.B. Murphy
Detailed reviews describing work presented at the annual Cold Spring Harbor Symposia on Quantitative Biology

1 November 1996 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
VRValter Redoglia
Valter Redoglia
UDUmberto Dianzani
Umberto Dianzani
JRJosè M. Rojo
Josè M. Rojo
PPPilar Portolés
Pilar Portolés
MBManuela Bragardo
Manuela Bragardo
CJCharles A. Janeway Jr.
Charles A. Janeway Jr.

1 May 2000 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
EFElena FernánDez-Centeno
Elena FernánDez-Centeno
GOGloria de Ojeda
Gloria de Ojeda
JRJosé M Rojo
José M Rojo
PPPilar Portolés
Pilar Portolés
It is known that certain type I membrane molecules (complement receptors type 1 and 2) belonging to the regulators of complement activation (RCA) family are involved in the regulation of B lymphocyte activation. In contrast, only GPI-anchored RCA molecules (CD55) have been described to be involved in T lymphocyte activation. In this study, we describe a novel function for the mouse RCA type I membrane protein Crry/p65 as a costimulatory molecule in CD4+ T cell activation. This is shown by increased anti-CD3-induced proliferation of CD4+ spleen T lymphocytes in the presence of the Crry/p65-specific mAb P3D2. Furthermore, Ab-induced coligation of Crry/p65 and CD3 favors IL-4 rather than IFN-γ secretion in these cells. Crry/p65 signaling was also observed regardless of additional Ca2+, protein kinase C, or CD28-mediated costimuli. Analysis of intracellular intermediaries shows that Crry/p65-CD3 coligation enhances certain TCR/CD3-mediated signals, producing increased early tyrosine phosphorylation of many substrates and enhanced activation of the mitogen-activated protein kinase, extracellular signal-related kinase. These data fit well with the association of Crry/p65 with the tyrosine kinase Lck found in T cell lysates. The epitope recognized by the mAb P3D2 interferes with the protective role of Crry/p65 on C3 deposition. The relationship between protective function and costimulation by Crry/p65 is discussed. Our results support a multifunctional role for Crry/p65 in T cells and suggest new links between the natural and adaptive immune responses.

1 June 1989 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
CJCharles A. Janeway
Charles A. Janeway
JRJose Rojo
Jose Rojo
KSKaj Saizawa
Kaj Saizawa
UDUmberto Dianzani
Umberto Dianzani
PPPilar Portolés
Pilar Portolés
BJBarry Jones
Barry Jones